1 results match your criteria: "University College London at Royal Free Hospital London[Affiliation]"
Hydroxychloroquine in dermatology: New perspectives on an old drug.
Australas J Dermatol
May 2020
Division of Medicine, Centre for Rheumatology and Connective Tissue Diseases, University College London at Royal Free Hospital London, London, UK.
Hydroxychloroquine is an age-old drug whose use as an immunomodulatory agent with a low side-effect profile continues to expand. We present a review of this drug including recently updated prescribing recommendations and a summary of its clinical application in dermatology. A maximum daily dose of 5.
View Article and Find Full Text PDF